Haven Capital Group, Inc. Bristol Myers Squibb CO Transaction History
Haven Capital Group, Inc.
- $107 Billion
- Q4 2025
A detailed history of Haven Capital Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Haven Capital Group, Inc. holds 6,023 shares of BMY stock, worth $281,936. This represents 0.3% of its overall portfolio holdings.
Number of Shares
6,023
Previous 7,839
23.17%
Holding current value
$281,936
Previous $354 Million
8.19%
% of portfolio
0.3%
Previous 0.32%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,732Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...